Commission Implementing Decision (EU) 2022/325 of 24 February 2022 amending Implementing Decisions (EU) 2015/698, (EU) 2017/2448, (EU) 2017/2452, (EU) 2018/1109, (EU) 2018/1110, (EU) 2019/1304, (EU) 2019/1306 and (EU) 2021/1388 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of, or produced from certain genetically modified organisms (notified under document
2022年2月24日委员会执行决定(EU)2022/325修订执行决定(EU)2015/698 (EU)2017/2448 (EU)2017/2452 (EU)2018/1109 (EU)2018/1110 (EU)2019/1304 (EU)2019/1306和(EU)2021/1388 关于授权持有人及其在欧盟的代表在市场上销售包含以下内容的产品: 或由某些转基因生物生产(根据文件通知
Commission Implementing Decision (EU) 2022/325 of 24 February 2022 amending Implementing Decisions (EU) 2015/698, (EU) 2017/2448, (EU) 2017/2452, (EU) 2018/1109, (EU) 2018/1110, (EU) 2019/1304, (EU) 2019/1306 and (EU) 2021/1388 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of, or produced from certain genetically modified organisms (notified under document C(2022) 1049) (Only the Dutch text is authentic) (Text with EEA relevance)